ARKB vs ARKG

ARK 21Shares Bitcoin ETF vs ARK Genomic Revolution ETF

Quick take
  • ARKB has the lower expense ratio at 0.21% vs 0.75% for ARKG.

Side-by-side metrics

MetricARKBARKG
Expense ratio
Annual fee. Lower is better.
0.21%0.75%
Dividend yield
Trailing 12-month yield.
0.00%0.00%
AUM
Assets under management — bigger funds are typically more liquid.
$1.89B$1.73B
YTD return
-28.96%44.53%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.002.38
P/E ratio
Last price
$20.95$43.17
Inception
Issuer
ARKARK

ARKB top holdings

Holdings data unavailable for ARKB.

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp9.15%
TEMTempus AI Inc Class A common stock7.64%
ABSIAbsci Corp7.01%
TXG10x Genomics Inc Ordinary Shares - Class A7.00%
CRSPCRISPR Therapeutics AG6.56%
PSNLPersonalis Inc6.19%
BEAMBeam Therapeutics Inc4.34%
GHGuardant Health Inc4.28%
NTRANatera Inc4.11%
ILMNIllumina Inc3.98%
Sector breakdown · ARKG
Healthcare100.0%

About ARKB

ARKB (ARK 21Shares Bitcoin ETF) is Spot Bitcoin ETF from ARK and 21Shares. Managed by ARK, the fund carries $1.9B in assets under management, an expense ratio of 0.21%.

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.